Worldquant has reduced its short position in the probiotic company Biogaia to below 0.5 percent of the capital and is therefore no longer a public short seller.
There are no public short sellers in the company. In total, 1.23 percent of the capital is shorted in the company.
Worldquant is a US-based quantitative asset manager.
The Swedish Financial Supervisory Authority requires positions above 0.1 percent to be reported and short positions above 0.5 percent to be made public.
